{"id":"F2007B01065","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 5 of 2003)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-2003","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62553,"registerId":"commonwealth-F2007B01065-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 5 of 2003)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85(2AA)\n\nNo. PB 5 of 2003\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:\n\n1. This Declaration commences on 1 May 2003.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nBumetanide\n\nUrofollitrophin\n\nDated this tenth day of April 2003.\n\nJOAN CORBETT\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1201},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This instrument performs exactly its stated function of delisting two specific pharmaceutical benefits. There is no evidence of scope creep; the declaration precisely removes Bumetanide and Urofollitrophin from PBS subsidization as originally intended."},"complexity_factors":["Single operative provision affecting only two named substances","No conditional logic, exceptions, or nested provisions","No defined terms or interpretation section","Straightforward commencement mechanism"],"plain_english_summary":"This declaration **removes government subsidies** for two specific prescription medications from 1 May 2003.\n\n**What this means:** The Pharmaceutical Benefits Scheme (PBS) is the system where the Australian government subsidizes the cost of medicines. When a drug is removed from Part VII of the National Health Act (what this declaration does), it ceases to be a \"pharmaceutical benefit.\" Patients must then pay the **full unsubsidized price** rather than the discounted PBS price.\n\n**The two drugs affected:**\n* **Bumetanide** — a diuretic (\"water pill\") used to treat fluid retention caused by heart, kidney, or liver conditions\n* **Urofollitrophin** — a fertility hormone used in IVF and other assisted reproductive treatments\n\nThis decision followed advice from the Pharmaceutical Benefits Advisory Committee, which reviews whether medicines offer sufficient value to justify continued taxpayer funding."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-2003","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-2003/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-2003/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-2003/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-2003/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-2003/documents"}}